DAIT supports extramural basic, pre-clinical and clinical research focusing on immune-mediated diseases through a variety of research grants and contracts.
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
Key research areas include newly emerging and re-emerging infectious diseases such as tuberculosis and influenza, HIV/AIDS, biodefense, and immune-mediated diseases including asthma and allergy. Please register by completing this survey.Each company is limited to four attendees. There is a 400-person registration limit. This event substitutes for the NIH Small Business Program Office's March 2022 1-on-1 consultations.
Visualization Tools for Infectious and Immune-mediated Disease ResearchTopic 123 - Data Science Tools for Infectious and Immune-mediated Disease ResearchNATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI): Topic 113 - Clinical Instrument for Para-Hydrogen (pH2) Based Signal Amplification by Reversible Exchange (SABRE) for Hyperpolarizing 13C-Pyruvate and Other Probes for MRI ImagingTopic 114 - Device to Permit Continuous Self-Monitoring of Blood Oxygen
, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases.
Project BackgroundThe National Institute of Allergy and Infectious Diseases (NIAID) is the nation’s premier medical research institute within the National Institutes of Health (NIH) focused on leading basic, preclinical, and clinical research to inform the development and testing of new and improved vaccines, therapeutics, and diagnostics to treat, and prevent infectious and immune-mediated diseases.
medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases.
